A Statement from Lung Cancer Alliance on the Death of Paul Newman
September 27th, 2008
Two months ago reports began to appear in the press that Mr. Newman was undergoing treatment for lung cancer. Many of those reports referred to him a “former chain smoker” with all the insinuations inherent in that label.Mr. Newman was first and foremost a great man and we mourn his passing.
Over 215,000 people will be diagnosed with lung cancer this year, and the majority will die within 12 months. More people die from lung cancer than breast, prostate, colon, kidney, melanoma and liver cancers combined. Over half of them are former smokers many of whom quit decades ago and did not even realize that they will always be at higher risk. Another 15% have never smoked at all. Yet, the stigma and the blame associated with lung cancer, and the small number of people who survive to fight this, have made lung cancer the least funded of the major cancers in federal research dollars per death.
Physicians seldom responded empathetically to the concerns of patients with 
 
Biologics, Inc., the leading oncology management company, is pleased to announce that a new oral drug for the treatment of relapsed small cell 
Today, Lung Cancer Alliance (LCA) commended the support of Senators Barbara Boxer (D-CA), Sam Brownback (R-KS), Thad Cochran (R-MS) and David Vitter (R-LA) as cosponsors of S.3187: The 
Testing lung fluid samples for levels of surfactant protein D (SP-D), which is thought to have a protective effect on the lungs, may help identify patients with a high risk of 
BioView Ltd, from Rehovot, Israel, reported results of its internal clinical trial of the non-invasive diagnostic test under development for early detection of 
Chukwumere E. Nwogu, MD, Department of Surgery at Roswell Park Cancer Institute, has been awarded grants from has been awarded grants from the National Cancer Institute and the Thoracic Surgery Foundation totaling nearly $1.2 million to investigate the effectiveness of an intra-operative gamma probe in staging of 
Ms. Kelly will address her story in caring for a son with cancer, and how he has turned his survivorship into an unprecedented advocacy effort. Ms. Kelly will be joined by Dr. Deborah Morosini who became a passionate advocate for 
Oregon Health & Science University Cancer Institute researchers have found the right formula of radiation and immunotherapy for fighting